Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synthetic intramembrane proteolysis receptors (SNIPRs) are engineered, modular cell-surface receptors designed to enable precise and programmable control of cellular responses. They function by coupling extracellular ligand recognition to the release of an intracellular transcription factor via regulated intramembrane proteolysis, thereby activating specific genetic programs in response to defined external signals. SNIPRs are composed of an extracellular ligand-binding domain, a transmembrane core, and an intracellular effector domain. Upon ligand binding, the receptor undergoes conformational changes that expose a cleavage site within the transmembrane region, leading to protease-mediated cleavage and release of the transcription factor.
Ligand-induced intramembrane proteolysis leading to transcription factor release and target gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synthetic Intramembrane Proteolysis Receptor (SNIPR).